Adult doses for migraine and headache treatments including barbiturates, ergot alkaloids, and NSAIDs.
Cancer survivors have a high prevalence of chronic pain.
The proportion of participants with cancer who used marijuana increased 118% from the period of 2005 to 2014.
CDC guidelines published in 2016 on prescribing opioids for chronic pain prompted questions regarding their application to patients with cancer and sickle cell anemia.
Cancer patients more likely to use sublingual tincture form; noncancer patients often use vaporization form
Lazanda (transmucosal immediate release fentanyl [TIRF]) is now available at a 300 mcg dose strength to treat breakthrough cancer pain.
Rotation to methadone as a second-line opioid may be safe and efficacious when using a tiered scheme with close follow-up in patients.
Low-dose morphine may effectively reduce pain intensity compared with weak opioids in patients with cancer who have moderate pain.